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1. Introduction 
Elongation factor Tu (EF-Tu) of E. coli possesses a
remarkable variety of functions and properties. In 
addition to having a role in protein biosynthesis [l] , 
EF-Tu is a component of Q/3 RNA replicase [2] and a 
regulator of RNA polymerase activity [3] , and is 
coded for by two genes [4] . EF-Tu is also reported 
to be associated with membranes [5] and to have 
actin-like properties [6] . In conjunction with X-ray 
crystallographic studies currently in progress [7,8], 
we have undertaken the amino acid sequence analysis 
of EF-Tu. In this report we describe the sequence of 
nearly half the molecule, and discuss some tentative 
conclusions that can be made about its structure. 
2. Materials and methods 
EF-Tu was purified from E. coli B as described by 
Miller and Weissbach [9]. 
A 400-mg sample of [ 14C] carboxymethylated 
EF-Tu was cleaved with 1 .l g of CNBr in 70% HCOOH 
for 22 h. The solvent was evaporated, and the mix- 
ture was suspended in 25% HOAc and centrifuged to 
remove undissolved material (mostly CB-3 and CB-7; 
see fig.1); the supernatant was then chromatographed 
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on Sephadex G-50 in 25% HOAc. Five fractions were 
obtained. Peptides CB-2 and CB-4 were isolated as 
precipitates by adjusting the pH of fraction 1 to pH 6 
and 3 to pH 7.8, respectively. The remaining peptides 
were separated by chromatography on DEAE Biogel 
and QAE Sephadex using NH4HCOJ buffers. 
Overlapping peptides were obtained by digestion 
of [“Cl carboxymethylated EF-Tu with 2% (w/w) of 
trypsin in 0.1 M NH4HC03, pH 7.8. Peptides were 
separated on Sephadex G-25, DEAE Biogel and QAE 
Sephadex in NH4HC03 buffers. Cysteine peptides 
were located by radioactivity and methionine peptides 
by spraying thin-layer chromatograms of fractions 
with PdCIZ [lo] . 
Cleavage of unmodified EF-Tu by 2-[‘4C]nitro-5- 
thiocyanatobenzoic acid (NTCB) in 6 M guanidine 
HCl was performed according to Jacobson et al. [ 1 l] . 
The NTCB peptides were separated by chromatography 
on Sephadex G-75 in 10% HOAc and on DEAE Biogel. 
Purity and size were assessed by SDS-urea gel electro- 
phoresis [ 121. 
Peptides were analyzed on a Beckman Model 119C 
amino acid analyzer and were sequenced by solid-phase 
Edman degradation [ 13,141 on a Sequemat Model 12 
sequencer or manually [ 151. Phenylthiohydantoins 
were identified by thin-layer chromatography and by 
HI hydrolysis to amino acids. 
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3. Results 4. Discussion 
Cyanogen bromide cleavage produced eleven pep- 
tides ranging in length from 2 to about 110 residues. 
The eight smaller peptides, except for CB-4 and CB-5 
(see fig.1 and 2), which had been reported [ 161 earlier, 
were sequenced entirely. The C-terminal regions of the 
three large peptides, CB-1, CB-2 and CB-3, were se- 
quenced by solid-phase Edman degradation after tryptic 
digestion and selective attachment [ 17,181 of the 
C-terminal homoserine moiety to the sequencing resin. 
The N-terminal regions of these peptides, except for 
CB-1 which is blocked, were obtained by manual 
Edman degradation. 
Alignment of the cyanogen bromide peptides was 
accomplished by isolation and characterization of the 
overlapping tryptic peptides containing methionine 
- (fig.1). It is a pecularity of EF-Tu that all of the 
sulfur-containing amino acids (3 Cys and 10 Met) are 
located in only six tryptic peptides. Additional con- 
firmation of the sequence was obtained by cleaving 
the protein at cysteine with 2-nitro-5-thiocyanato- 
benzoic acid and isolating three of the theoretical four 
NTCB fragments. The cleavage yields at Cys-1 , -2, and 
-3 (numbering from the N-terminus) were calculated 
to be approximately 18%, 25% and SO%, respectively. 
Further fragmentation of the NTCB peptides by cyano- 
gen bromide, followed by peptide mapping, gave 
the peptides expected from the proposed sequence 
(figs.1 and 2). 
The sequence shown in fig.2 accounts for 180 of 
the approximately 400 amino acid residues in EF-Tu. 
EF-Tu contains three cysteines, one of which (Cys-1, 
fig.1) is associated with tRNA binding and a second 
(Cys-2) with GTP binding; the third cysteine has no 
known function [ 19,201 . The sequence of the tryptic 
peptide containing Cys-2 (T2) was reported earlier by 
Wade et al. [ 161 and those containing Cys-1 (T6) and 
Cys-3 (Tl) by Nakamura et al. [2 I] . Our sequence 
data for Tl and T6 agree with those of Nakamura 
et al. [21] , except that we find methionine in Tl, 
whereas the other investigators did not. There can be 
no doubt that methionine is present, since Tl can be 
cleaved with CNBr. 
The present work shows that the cysteine at the 
tRNA site (Cys-1) is about 100 residues from the 
N-terminus and that at the GTP site (Cys-2) is at 
about position 156. Arai et al. [22] and Cast et al. 
[7] have shown that limited trypsin digestion of 
EF-Tu removes a fragment of 6-10 000 daltons from 
the N-terminus, and that such treatment abolishes 
tRNA, but not nucleotide, binding. Thus the trypsin 
cleavage point must be at least 10 residues ahead of 
Cys-1 in the polypeptide chain. Either portions of the 
tRNA binding site reside in the N-terminal tryptic 
fragment or loss of the fragment disrupts the confor- 
mation of the binding site at Cys-1. 
Using the parameters of Chou and Fasman [23] , 
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Fig.1. Alignment of cyanogen bromide peptides of EF-Tu with overlapping tryptic and NTCB peptides. Cys-1 and Cys-2 are 
cysteines at the tRNA and GTP binding sites, respectively. The shaded areas indicate regions that have been sequenced. 
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100 *T-T6 --CBl -CB9 
Val-Asp-~Pro-Gly-His-Ala-Asp-Tyr-Val-Lys-Asn-Met-Ile-Thr-Gly-Ala-Ala-Gln-Met-Asp-Gly- 
L11 
125 tCB7 -T4 
Ala-Ile-Leu-Val-Val-Ala-Ala-Thr-Asp-Gly-Pro-Met-Pro-Gln-Thr-Arg-Glu-His-Ile-Leu-Leu-Gly- 
150 eCB4 
Arg-Gln-Val-Gly-Val-Pro-Tyr-Ile-Ile-Val-Phe-Leu-Asn-Lys-~Asp-Met-Val-Asp-Asp-Glu-G1u- 
W\ I219 
-CBS =T2 175 
Leu-Leu-Glu-Leu-Val-Glu-Met-Glu-Val-Arg-Glu-Leu-Leu-X-Gln-Tyr-X-Phe-(AspgThr2Ser3Glul4Pro5 
JUJJWUUWWU 
Gly10Ala7Va1211e7Leu7TyrlPhelLys4Arg5Trp2_3 
tCB3 -Tl 
275 
Leu-Leu-Asp-Glu-Gly-Gly-Ala-Gly-Glu-Asn 
JYUWU 
350 
SerlGlugPro4G1y5Ala2Val4Ile5Leu3~r2Phe4His3Lys7Arg4)-Thr-Thr-Asp-Val-Thr-Gly-Thr-Ils-Glu- 
eCB2 eCB10 -T5-CBll 
Leu-Pro-Glu-Gly-Val-Glu-Met-Val-Met-Pro-Gly-Asp-Asn-Ile-Lys-Met-Val-Val-Tr-Leu-Ile-His- 
375-CBB eT3 
Pro-Ile-Ala-Met-Asp-Asp-Gly-Leu-Arg-Phe-Ala-Ile-Arg-Glu-Gly-Gly-Arg-Thr-Val-Gly-Ala-Gly- 
400-CB6 
Val-Val-Ala-Lys-Val-Leu-Ser-OH 
Fig.Z.Partial amino acid sequence of EF-Tu.Tryptic and cyanogen bromide peptides are indicated by the peptide number over 
the C-terminal amino acid of each peptide. An overlapping chymotryptic peptide, Val-Lys-Asn-Hse, from CBl established the 
position of T6. Coiled lines designate predicted a-helical regions and zigzag lines p-sheet; the two C-terminal P-regions appear to 
be linked by p-turn. 
we have calculated that the sequenced portion of 
EF-Tu contains about 20% a-helix and 35% P-sheet. 
The predicted conformations are indicated schema- 
tically in fig.2. Particularly noteworthy are the fl-struc- 
ture and p-turn near the C-terminus and an extended 
a-helical stretch following Cys-2. This region com- 
prises most of peptide T2, which was found earlier 
[ 151 to crystallize spontaneously at about pH 4. 
Actin 
284 
EF-Tu 
156 
Fig.3. Possibly analogous sequences in EF-Tu and rabbit muscle actin. No other similarities have yet been detected. Dashed lines 
indicate residues of similar type (acidic or hydrophobic). 
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Beck et al. [$I have noted that EF-Tu and the 
contractile protein, actin, have a number of similari- 
ties in terms of size, amino acid composition and a 
variety of reactions and functions, and have suggest- 
ed that the two proteins may be evolutionarily related. 
We have compared our sequence data with that for 
rabbit muscle actin and find that there is indeed some 
similarity in the sequence around Cys-156 (Cys-2) of 
EF-Tu and Cys-284 [24] of actin (fig.3). However, 
the similarities do not extent beyond this region. 
Furthermore the two cysteine residues occupy quite 
different positions in their respective polypeptide 
chains, which are of similar lengths. We conclude 
therefore that the proteins are not homologous; the 
observed similarities may be characteristic of a nucleo- 
tide binding site (for GTP or ATP) which arose by 
convergent evoluation. 
Escherichia coli possesses two genes that code for 
EF-Tu [4], which suggests the possibility that there 
may be two forms of the protein. Thus far, however, 
we have found no evidence of allotypes. In addition, 
peptide mapping studies in our laboratory and in 
Furano’s [25] on the isolated tufA and r~fB gene 
products have shown that the two proteins are very 
similar, if not identical. 
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